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Viruses belonging to the Papillomaviridae family have been isolated from a variety of mammals, birds
and non-avian reptiles. It is likely that most, if not all, amniotes carry a broad array of viral types. To date,
the complete genomic sequence of more than 240 distinct viral types has been characterized at the
nucleotide level. The analysis of this sequence information has begun to shed light on the evolutionary
history of this important virus family. The available data suggests that many different evolutionary
mechanisms have inﬂuenced the papillomavirus phylogenetic tree. Increasing evidence supports that the
ancestral papillomavirus initially specialized to infect different ecological niches on the host. This episode
of niche sorting was followed by extensive episodes of co-speciation with the host. This review attempts
to summarize our current understanding of the papillomavirus evolution.
Published by Elsevier Inc.Introduction
Papillomaviruses have been discovered in a wide array of verte-
brates (Rector and Van Ranst, in press, and references therein).
Remarkably, in those hosts that have been extensively studied (e.g.
humans, cattle, dogs, etc.), an extensive repertoire of highly species-
speciﬁc viruses has been described. With over 240 distinct types
classiﬁed in 37 genera, papillomaviruses may be the biggest and
most successful family of vertebrate viruses (Bernard et al., 2010; de
Villiers et al., 2004; Van Doorslaer et al., 2013). It is clear that
papillomaviruses have been, and continue to be, an astonishing
evolutionary success.
The double stranded papillomavirus genome ranges from
6953 bp [Chelonia mydas papillomavirus type 1 (CmPV1)] to
8607 bp [Canine papillomavirus type 1 (CPV1)] in length. Due to
their clinical importance, the relatively small genomic size and
recent advances in cloning and sequencing methods the complete
genomic sequences of most identiﬁed viral types is available to
researchers. This treasure-trove of complete genomic sequence
data in combination with clinical and biochemical data has
made papillomaviruses an ideal model system to understand
how evolution affects different aspects of the viral lifecycle.
It has been shown that papillomaviruses have a slow evolutionary
rate, suggesting that genetic drift is mainly responsible for viral
diversity. Indeed, given that papillomaviruses infect their hosts
for very long periods of time, it remains an open question whatInc.additional types of evolutionary pressure (if any) should be
expected to shape the viral genome.
This review presents an account of our current understanding
of the papillomavirus evolutionary history. The more we learn
about the evolution of papillomaviruses, the more “nothing in
biology makes sense except in the light of evolution” (Dobzhansky,
1973) rings true.Papillomaviruses co-speciated with their hosts
Historically, viral evolution has mainly been considered from a
predator–prey perspective. Under this model, viral ﬁtness (and
thus its evolutionary success) is measured by the viral capacity to
cause disease in its host (Shadan and Villarreal, 1995). However,
papillomaviruses (and other small DNA viruses) cause benign,
mostly unapparent, persistent infections in their hosts. In addition,
papillomaviruses are highly host-restricted, and cause abortive
infections in non-host species. In fact, the only exceptions to strict
species speciﬁcity were described in mammalian hosts known to
hybridize (Chen et al., 2009; Gottschling et al., 2011a), thereby
challenging the hosts' species deﬁnition. The observation that
papillomaviruses cause benign infections unable to cross the hosts'
species-barrier has led to the hypothesis of “host-linked evolution”
(Bernard, 1994; Sundberg et al., 1997).
The traditional (orthogenetic) deﬁnition of co-evolution
states that parasites of closely related host species should be
closely related themselves and cluster together in the parasite
phylogenetic tree. Furthermore, dates associated with parasite
Fig. 1. Papillomavirus phylogenetic tree. The DNA sequence coding for E1, E2, L1 and L2 for all 241 papillomaviruses currently on PaVE were downloaded and aligned. A
partitioned gene alignment was used as the base for a maximum likelihood reconstruction of the phylogenetic tree. The different papillomavirus genera are named according
to Bernard et al. (2010) and de Villiers et al. (2004). Genera marked with an asterisk have been proposed to the ICTV, and are awaiting ofﬁcial recognition (http://talk.
ictvonline.org/ﬁles/proposals/taxonomy_proposals_vertebrate1/m/vert01/4244.aspx). The tree is color-coded according to presence/absence of the “adaptive proteins”. Red
clades lack an E6 ORF. The viruses highlighted in green do not code for an E7 protein. The purple clades code for a hydrophobic E5 protein. The Xipapillomaviruses lack an E6
(red), but contain an E5 (purple).
K. Van Doorslaer / Virology 445 (2013) 11–2012divergence should coincide with the host-species divergence
(Fahrenholz's rule; Hafner and Nadler, 1988). Therefore, any
incongruence between both trees should be considered as
evidence that parasite and host did not co-evolve (Brooks,
2003; Page, 2002).
With an increase in the number of papillomavirus sequences
(and their associated hosts), it became clear that papillomaviruses
and their hosts did not follow an identical evolutionary path
(Bravo and Alonso, 2007; Chan et al., 1992, 1995, 1997a, 1997b;
Garcia-Vallve et al., 2005; Gottschling et al., 2007a, 2007b;
Narechania et al., 2005a; Rector et al., 2008). Several violations
of strict co-evolution can be observed in the phylogenetic tree
in Fig. 1. For example, human papillomaviruses can be found in
ﬁve different genera (Alpha, Beta, Gamma, Mu and Nu) dispersed
throughout the phylogenetic tree. Also, strict co-evolution would
place the non-human primate papillomaviruses basal to human
papillomaviruses, not intermingled as is observed.
Evolutionary events such as cross-species infection, recombi-
nation and virus duplication (e.g. following ecological niche
adaptation) have been suggested to explain the observed conﬂicts
(Angulo and Carvajal-Rodriguez, 2007; Carvajal-Rodriguez, 2008;
Gottschling et al., 2011b; Halpern, 1995; Shah et al., 2010; Varsani
et al., 2006). The impact of viral recombination will be discussed in
more detail later, but while the inﬂuence of recombination
has been limited, recombination likely played a role at speciﬁc
moments throughout viral evolution.Because of the absence of cross-species infections, it is unlikely
that horizontal gene transfer played any role in the evolution
of the Papillomaviridae. In fact, a study speciﬁcally looking at the
inﬂuence of horizontal gene transfer identiﬁed only a single
potential cross-species transmission event. This event involved
ancestors of a porcupine (EdPV1) and human (HPV41) papilloma-
virus (Shah et al., 2010). These two viruses are the only members
of a divergent genus (Nupapillomavirus); it will be of interest to see
how the inclusion of more viruses in this genus will affect the
conclusion of cross-species infection.
A more recent version of the co-evolution theory was initially
proposed in the early 1960s (reviewed in Brooks and Ferrao, 2005).
This updated theory states that the evolution of parasites follows the
evolution of host resources, not the evolution of the host species per-
se. The shape of the papillomavirus phylogenetic tree could potentially
be explained using this interpretation of co-evolution. Under this
model, speciﬁc events in the evolution of hosts (e.g. presence/absence
of fur, evolution of sweat glands, etc.) created new ecological niches for
papillomaviruses to adopt (Bernard et al., 1994). Therefore, the data
suggests a model in which a generalist ancestral papillomavirus
diverged into four or ﬁve increasingly specialized viruses (reﬂected
in the 4–5 major clades of the phylogenetic tree) (Bravo and Alonso,
2007). Following these niche adaptation events, the virus evolved
alongside its hosts. Throughout the co-evolutionary process, the
availability of new niches would in turn drive viral radiation, followed
by further co-speciation.
K. Van Doorslaer / Virology 445 (2013) 11–20 13In conclusion, the papillomavirus phylogenetic tree cannot be
explained solely by co-evolution. However, initial niche sorting
followed by virus–host linked speciation was a key determinant ofTable 1
Papillomaviruses gained and lost “adaptive proteins” several times throughout
evolution.
Genus (species) E6 E7 E5
Deltapapillomavirus (1–5) Yes Yes Yes
Gammapapillomavirus (6) No Yes No
Upsilonpapillomavirus (all) Yes No No
Omikronpapillomavirus (all) Yes No No
Omegapapillomavirus (all) Yes No No
Dyopipapillomavirus (all) Yes No No
Dyodeltapapillomavirus (all) Yes No No
Xipapillomavirus (all) No Yes Yes*
Alphapapillomavirus (5–7, 9 and 11) Yes Yes E5α
Alphapapillomavirus (2–4 and 14) Yes Yes E5β
Alphapapillomavirus (10) Yes Yes E5γ and E5δ
Alphapapillomavirus (8) Yes Yes E5δ
Alphapapillomavirus (12) Yes Yes Yes&
Kappapapillomavirus Yes Yes Yes
Not all extant papillomaviruses encode an E1, E2 (and E4), E6, E7, L2 and L1 ORF. Viral
genera (species indicated by number) that gained an E6, E7 or lost an E5 ORF are
listed. The Alphapapillomavirus E5 ORFs are named according to Bravo and Alonso
(2004). Please note that the species nomenclature of the Alphapapillomaviridae was
updated in 2010 (Bernard et al., 2010), explaining some discrepancies between
Table 1 and the paper by Bravo and Alonso (2004). The E5 proteins found in viruses
belonging to the Alphapapillomavirus species 12 (indicated by &) were not discussed
in the paper by Bravo and Alonso (2004), and were therefore not speciﬁcally named.
The E8 protein encoded by the members of the Xipapillomaviruses was renamed E5
(indicated by asterisk).
Delta-1/2/3/4 and 5
E5 ORF
Kappa
E5 ORF
Alpha-5/6/7/9 and 11
E5 ORF*
Alpha-2/3/4 and 14
E5 ORF*
Alpha-10
E5 ORF*
Alpha-8
E5 ORF*
Upsilon/Omikron/
Dyopi/Dyodelta
no E7 ORF
Xi#
no E6 ORF
contains E5 ORF
Gamma-6/Theta
no E6 ORF
“Prototype” papillomavirus
Genus (or species)
presence /abscence of ORF
Fig. 2. Gains and losses of “adaptive proteins” throughout papillomavirus evolution. Gra
viral proteins. Each ORF is represented by a rectangle. Viral genera (or species) are indica
The red boxes indicate viral ORFs different from the prototypical PV genome. The E5 pro
according to Bravo and Alonso (2004). The E5 proteins found in viruses in the genus Xipthe papillomavirus evolutionary history (Gottschling et al., 2011b;
Shah et al., 2010).Gains (and losses) of “adaptive proteins” drive papillomavirus
evolution
All known papillomaviruses encode for at least ﬁve proteins
(E1, E2 (and E4), L1 and L2). E1 and E2 are key modulators of
replication and transcription, while the L1 and L2 structural
proteins make up the viral capsid. The E4 protein is embedded
within the E2 protein and is expressed as a very abundantly
spliced transcript. In addition to this core set of proteins, all
papillomaviruses contain an untranslated long control region
(LCR) located between the L1 and E6 ORFs. The LCR contains
elements required for transcription and replication (Garcia-Vallve
et al., 2005). Most viruses also encode proteins (E5, E6 and E7)
involved in modulating cellular growth and immune responses
(Klingelhutz and Roman, 2012). In the cancer-associated viruses,
these proteins have been shown to be oncogenic. The phylogenetic
tree in Fig. 1 illustrates that certain evolutionary groups are
“apomorphic” for the presence/absence of these non-core proteins
(green clades lack an E7 protein; red clades do not encode an E6.
The Alpha-, Delta- and Kappapapillomaviruses contain an E5 ORF;
summarized in Table 1). Theoretically, a putative virus consisting
of the core set of features (LCR, E1, E2, L2 and L1) should be able to
fulﬁll the basic requirements (replication, transcription and viral
packaging) of a viral infection. It is therefore tempting to hypothe-
size that the ancestral papillomavirus did not contain any “adap-
tive proteins” (E5, E6 and/or E7). However, all known viruses
contain at least one of these proteins (Table 1 and Fig. 2).phical representation of different viral genomes illustrating the loss and/or gain of
ted at the left, and a representative viral type is used to illustrate genomic features.
teins found in members of the Alphapapillomaviruses (indicated by “*”) are labeled
apillomaviruses (indicated by “#”) were previously named E8 (O'Brien et al., 2001).
K. Van Doorslaer / Virology 445 (2013) 11–2014While it is hard to speculate on the evolutionary origin of these
individual building blocks, it is likely that at least some of these
components were already available for incorporation into (papil-
loma-) viral genomes. This idea is supported by the relatively high
sequence similarity between the helicase motifs of the papilloma-
virus E1 protein, the polyomavirus large T-antigen (Clertant and
Seif, 1984), the parvovirus NS1 protein (Astell et al., 1987), and a
virus-like element found in certain ﬂatworms (Rebrikov et al.,
2002). While it is impossible to exclude convergent evolution, it is
tempting to speculate on a shared evolutionary history of these
viral proteins (Bernard, 2013).
The mammalian E6 proteins contain two highly conserved 70-
residue zinc-binding repeats (Zanier et al., 2013). Interestingly, the
avian papillomavirus E6 protein consist of a single zinc-binding
domain that is closely related to the C-terminal domain of the
mammalian E6 protein. Phylogenetic evidence points towards the
existence of a comparable single-domain E6 protein in the proto-
papillomavirus (Van Doorslaer et al., 2009). The mammalian E6
N-terminal domains may have emerged by duplication and subse-
quently diverged from the original ancestral domain (Van Doorslaer
et al., 2009). The mammalian E7 proteins contain an unfolded
N-terminal region followed by a zinc-binding motif (Liu et al., 2006;
Ohlenschlager et al., 2006). Although the primary sequence of the E7
zinc-binding domain is highly reminiscent of the E6 domain (Cole and
Danos, 1987), it has a drastically different fold. While it is possible that
the different E6 and E7 proteins are the result of convergent evolution,1a
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Fig. 3. Evolution of the E6 and E7 proteins. The proto-papillomavirus may have conta
ancestral protein was similar to the single-domain E6 protein present in extant avian p
domains present in extant mammalian PVs are phylogenetically related to these single-do
binding motif. The presence of a conserved functional motif suggests common ancestry th
“E6/E7 like” protein duplicated, creating the two-domain E6 protein. The N-terminal dom
duplication was followed by an additional duplication that created the ancestral E7 pro
pathway 2, the duplication event giving rise to the E7 protein (path 2a) preceded the do
some viruses lost the E7 or the E6 protein (green and red branch respectively).the more parsimonious explanation suggests that an “E6/E7-like”
protein became part of the ancestral papillomavirus genome prior to
the initial niche adaptation and divergence at the root of the tree (see
above). While the order of events has not been clariﬁed, it is likely that
the extant E6 and E7 proteins arose through a series of duplication
events after which each protein diverged and adopted new functions
(Fig. 3). The low overall sequence similarity between E6 or E7 protein
from different viruses supports the notion that these proteins have
evolved to fulﬁll a diverse set of functions depending on the needs of a
particular viral type. Indeed, recent proteomic studies conﬁrm that
the set of cellular proteins targeted by the E6 and/or E7 proteins
are unique to a speciﬁc viral type (Rozenblatt-Rosen et al., 2012;
White and Howley, 2013; White et al., 2012a, 2012b). Remarkably,
these adaptations may manifest at the structural level. The recently
solved human (HPV16) and bovine (BPV1) E6 structures show that
both proteins evolved drastically different ways to interact with their
cellular targets (Zanier et al., 2013). This raises the possibility that the
functions performed by these proteins are not strictly essential to the
viral lifecycle, but that changes to these “adaptive proteins” allowed
viruses to adjust to new eco-systems on their hosts.
Given that the E6/E7 protein was acquired early in the evolu-
tion of the Papillomaviridae, the absence of these proteins in
certain viruses (Fig. 1) implies a loss of the ORF. Interestingly, the
loss of E6 appears to have occurred repeatedly throughout viral
evolution (Fig. 1, red clades). On the other hand, based on the
current sequence information, loss of E7 has only befallen related2a
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apillomaviruses (FlPV1 and FcPV1) (Van Doorslaer et al., 2009). The E6 C-terminal
main avian E6. Like the E6 proteins, the E7 protein contains a highly conserved Zinc
e E6 and E7 proteins (Cole and Danos, 1987). In alternative pathway 1, the ancestral
ain subsequently diverged from the original ancestral domain (path 1a). This initial
tein. Further evolutionary processes shaped the E7 protein (path 1b). In alternative
main duplication that created the two domain E6 (path 2b). Throughout evolution
Table 2
Summary of papillomavirus codon sites under positive selection.
ORF Codon position
(amino acid)
Reference
HPV16
E6 17 Arg DeFilippis et al. (2002), Chen et al. (2005)
and Carvajal-Rodriguez (2008)
21 Gln DeFilippis et al. (2002), Chen et al. (2005)
and Carvajal-Rodriguez (2008)
34 Ile DeFilippis et al. (2002)
90 Leu DeFilippis et al. (2002), Chen et al. (2005)
and Carvajal-Rodriguez (2008)
E5 48 Leun Chen et al. (2005)
65 Ilen Chen et al. (2005)
L2 378 Ser Carvajal-Rodriguez (2008)
HPV18
E5 72 Leu Chen et al. (2009)
HPV45
E6 21 Leu Chen et al. (2009)
L1 357 Sern Chen et al. (2009)
Codon sites under diversifying selection (dN/dS41) have been described in HPV16,
HPV18 and HPV45. The codon position and encoded amino acid are indicated. In
some cases (indicated with asterisk), the codon positions were renumbered in
order to be in agreement with the data in the PaVE database (Van Doorslaer et al.,
2013).
3
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10 / 13
0.2
L1 ORF E1ORFAlphapapillomavirusspecies
Fig. 4. Phylogenetic incongruence between early and late genes in the Alphapa-
pillomaviruses. Phylogenetic trees were inferred based on the L1 (late tree; left) and
E1 (early tree; right) using maximum likelihood (Guindon and Gascuel, 2003). Both
trees were based on all human viruses within the Alphapapillomavirus genus. The
different viral species were collapsed for improved readability. The solid branches
K. Van Doorslaer / Virology 445 (2013) 11–20 15viruses at the base of the genus Alphapapillomavirus (Fig. 1, green
clades).
While an early evolutionary event added an “E6/E7 like protein”
to the papillomavirus repertoire, several lines of evidence point
towards several entry events of the viral E5 ORF (Garcia-Vallve et al.,
2005). First, only members of the Alphapapillomavirus, Deltapapillo-
mavirus and possibly Kappapapillomavirus genera contain an ORF
coding for a hydrophobic protein in the traditional location (between
the E2 and L2 ORFs; Fig. 2) (Garcia-Vallve et al., 2005). Certain
members of the Xipapillomavirus genus lack an E6 gene and instead
have a short hydrophobic ORF in the same genomic location. This ORF
was originally termed E8 but shares characteristics of the E5 ORFs of
the Deltapapillomavirus genus (O'Brien et al., 2001). Second, besides
being hydrophobic in nature, these proteins do not share any chemical
features and do not appear to be homologous. For example, all
members of genus Alphapapillomavirus encode an E5 ORF, however
these proteins can be divided into four separate groups with diverse
chemical and evolutionary characteristics (Bravo and Alonso, 2004).
Consistent with its recent acquirement by the genome, the E5 protein
is one of few papillomavirus proteins showing evidence of evolu-
tionary selective pressure (Chen et al., 2005) (Table 2). Conﬁrming its
recent acquisition, presence/absence of the E5 protein was used to
demonstrate that the integration of the E5 ORF in the Deltapapilloma-
virus genus occurred between 65 and 23 million years ago (Garcia-
Vallve et al., 2005), following the divergence between Camelids and
the other ungulates.
It is tempting to speculate that the expansion of the viral arsenal
through acquisition of an E6/E7 allowed the proto-papillomavirus
to expand its reach into different ecological niches. The E6 and E7
proteins evolved and allowed each virus to become increasingly
specialized. However, evolutionary events selected for the loss of
these proteins from certain genomes. Likewise, a subset of papilloma-
viruses acquired an additional “adaptive protein” in the form of E5,
providing these viruses with another evolutionary tool.represent branch-lengths, while the dotted lines were added for ease of inter-
pretation. The viral species are named according to Bernard et al. (2010). Species
alpha-12 contains only non-human primate papillomaviruses and was excluded
from the analysis. The clade containing the oncogenic viruses is highlighted in red.
The red circle illustrates the position of the last common ancestor of the oncogenic
viruses within the high-risk clade. This tree shows that oncogenesis maps to the
early region, not the late ORFs (Narechania et al., 2005a). The scale bar indicates
nucleotide changes per site per year.Role of recombination during papillomavirus phylogenetic
evolution
The analysis of the papillomaviral evolutionary history is
complicated by the observation of both inter-genetic (i.e., earlyvs. late) and intra-genetic (e.g. within L2) phylogenetic incongru-
ence (Angulo and Carvajal-Rodriguez, 2007; Bravo and Alonso,
2007; Carvajal-Rodriguez, 2008; Garcia-Vallve et al., 2005;
Narechania et al., 2005a). Viral recombination events may provide
an explanation for these incongruent phylogenetic trees.
The best-studied examples of recombination events involve
papillomaviruses infecting the order Cetacea (whales, dolphins
and porpoises; Gottschling et al., 2011a; Rector et al., 2008). When
using the late proteins as the base of the phylogenetic tree, these
viruses cluster at the root of the Alphapapillomavirus genus.
However, the early genes suggest a closer relationship to the
Xi- and Phipapillomavirus genera containing viruses that infect
cows and goats respectively (Gottschling et al., 2011a). A possible
recombination event was mapped near the end of E2/beginning of
L2. A second possible recombination site was estimated to lie
within the viral LCR (Rector et al., 2008). A virus causing carcino-
mas in marsupials provides additional evidence for the occurrence
of recombination. This virus is likely to be the result of a
recombination event between members of the Papillomaviridae
and Polyomaviridae (Woolford et al., 2007).
In addition, computational studies have provided evidence
for a handful ancient recombination events, mainly occurring
within the L2 ORF (Angulo and Carvajal-Rodriguez, 2007;
Carvajal-Rodriguez, 2008; Shah et al., 2010; Varsani et al., 2006).
A recombination event at the root of the Alphapapillomavirus
genus (Narechania et al., 2005a; Varsani et al., 2006) could
potentially have important (clinical) implications. Within this
genus, phylogenetic trees inferred from the entire viral genome
cluster all cancer-causing types together, suggesting the existence
of a common ancestor for the oncogenic human papillomaviruses.
However, in separate trees built from the early open reading
frames (E1 and E2) or the late ORFs (L1, L2), the carcinogenic
potential sorts with the early region of the genome, but not the
late region (Fig. 4; Narechania et al., 2005a). A recombination
event at the root of the Alphapapillomavirus may explain this
observation (Varsani et al., 2006). However, since no experimental
evidence of recombination between Alphapapillomaviruses exists
one cannot exclude a role for convergent evolution following niche
adaptation (Castoe et al., 2009; Narechania et al., 2005a).
K. Van Doorslaer / Virology 445 (2013) 11–2016The key question is whether a recombination event between
two (related) viruses provides the recombinant virus with an
(adaptive) advantage over the non-recombinant donor viruses.
Through the process of co-evolution, each individual papilloma-
virus type has optimized its arsenal to successfully infect a speciﬁc
niche on their host for millions of years. It is therefore unlikely
that recombination events will get ﬁxed in the viral population.
A recent study provided evidence of several recombination events
between two HPV16 variants in a clinical sample (Jiang et al.,
2009). However, the recombinant viruses were not detected in
the follow-up samples, suggesting that the recombinant viruses
had lower ﬁtness compared to the parental viruses. Likewise, a
study using experimental infections of rabbits did not provide
clear evidence of successful recombination events (Hu et al., 2009).
It is important to consider whether vaccination could provide a
selective advantage to speciﬁc recombinants. It is conceivable that
a recombination event between HPV31 and HPV16 would create a
virus carrying HPV16 early (and onco-) genes while coding for the
HPV31 structural proteins. Theoretically, this virus would be
able to infect the vaccinated population. The pressure applied by
vaccination would provide this recombinant with a selective
advantage over parental HPV16.
To conclude, while recombination may have played an impor-
tant role during the evolution of papillomaviruses, it is likely that
these events mainly occurred early in the evolutionary process.
Two important caveats should be added to this conclusion. Firstly,
most methods designed to detect recombination events depend on
both donor sequences being present in the database. It is therefore
essential that the current efforts in viral discovery be continued.
Second, a bias exists in the way samples are collected and chosen
for further analysis. In many cases, viruses are detected by PCR
primers targeted at a conserved region within the L1 and/or E1
ORF (Rector et al., 2004). The sequence similarity to known viruses
in the database determines whether to continue the analysis,
thereby potentially missing interesting recombinants.
While the incongruences between the early and late trees are
the most striking, it has been shown that all the viral proteins (E1,
E2, E6, E7, L1 and L2) evolved (slightly) differently (Garcia-Vallve
et al., 2005; Van Doorslaer and Burk, 2010). The observation that
phylogenies derived from different proteins are incongruent with
each other has several important implications. First, it suggests
that evolutionary studies based on “concatenated” data sets (i.e.,
sequences from different genes are combined into a super-gene)
should be interpreted with care. In addition, no single gene tree
will accurately represent the evolutionary history of papilloma-
viruses as a whole, but rather represents the history of the single
gene used to construct the tree.Table 3
Papillomavirus evolutionary rates.
Evolutionary rate Reference
HPV18 variants Ong et al. (1993)
URR 4.510−7
Lambdapapillomavirus Rector et al. (2007)
Overall 1.95E-8 (1.32E-8–2.47E-8)
E1 1.76E-8 (1.20E-8–2.81E-8)
E2 2.11E-8 (1.52E-8–2.81E-8)
E6 2.39E-8 (1.70E-8–3.26E-8)
E7 1.44E-8 (0.97E-8–2.00E-8)
L2 2.13E-8 (1.46E-8–2.76E-8)
L1 1.84E-8 (1.27E-8–2.35E-8)
URR 2.69E-8 (1.75E-8 –3.69E-8)
108 Papillomaviruses Shah et al. (2010)
E1 7.110−9
L1 9.610−9
The mean evolutionary rates (95% conﬁdence interval) in nucleotide substitutions
per site per year as calculated for the different papillomavirus genes.Papillomaviruses evolve about ﬁve times faster than their
mammalian hosts
In order to estimate the evolutionary rate for fast evolving
viruses, it is usually sufﬁcient to obtain the genomic sequence
from samples taken at different time points. However, the obser-
vation that two isolates of bovine BPV1, collected 30 years apart
and from remote cattle populations (Sweden and USA), had nearly
identical sequences (Ahola et al., 1983) indicates that papilloma-
viruses evolve too slowly for this approach. Nevertheless, since
virus–host co-speciation is the main evolutionary force involved in
shaping the papillomavirus tree (see above), the hosts' divergence
times (based on molecular and fossil data) can be used to calibrate
a “molecular clock” (Drummond et al., 2006). For example, if the
fossil record suggests that two host species diverged at a certain
point in time, these hosts' viruses must have diverged at similar
times. This approach was used to estimate the evolutionary rate ofpapillomaviruses infecting carnivores in the Lambdapapillomavirus
genus (Rector et al., 2007). Based on host calibration points, an
evolutionary rate of approximately 1.9510−8 (95% conﬁdence
interval 1.3210−8 to 2.4710−8) nucleotide substitutions per site
per year was calculated for the viral coding genome. This rate
is comparable with another study which deﬁned an estimate
of 4.510−7 nucleotide substitutions per site per year for the
LCR (the most variable region) of the HPV18 genome (Ong et al.,
1993). In addition, a recent study based on the complete genome
sequence of 108 viruses estimated evolutionary rates of 7.110−9
(E1 gene) and 9.610−9 (L1 gene) (Shah et al., 2010) (Table 3).
These slow evolutionary rates suggest that mutations are ﬁxed
in the papillomavirus genome at a very low rate. In fact, based on
these calculations, papillomaviruses evolve approximately one
order of magnitude faster than mammalian host cellular genes,
which have a mutation rate of 2.210−9 nucleotide substitutions
per site per year (Kumar and Subramanian, 2002). This is likely
due to the high ﬁdelity, proofreading capacity of the host cell DNA
replication machinery. In addition, it appears that papilloma-
viruses are under strong purifying selection pressure (see below),
thereby further limiting the ﬁxation of new mutations in the viral
genome. In addition, the 5–10-fold increase in mutation rate may
be due to the small viral genome size (Drake, 1991; Lynch, 2010)
and shorter generation times, resulting in more replication cycles
per unit time.
The relative agreement between evolutionary rates derived from
different parts of the tree (Table 3) suggests that different parts of
the tree evolve at similar rates. Equal evolutionary rates across the
papillomavirus tree would allow researchers to apply the precise rates
calculated for a speciﬁc part of the phylogenetic tree to another part of
the tree. For example, the use of the Lambdapapillomavirus rates would
provide exact estimates of when certain members of the Alphapapillo-
mavirus genus acquired the oncogenic phenotype.
A recent study used 108 virus types to estimate the evolu-
tionary rates of the E1 and L1 ORFs (Shah et al., 2010). These rates
were slightly slower when compared to the rates reported for
the feline papillomaviruses (Rector et al., 2007). However, since
mounting evidence suggests that early niche sorting preceded co-
evolution, these “whole tree estimates” (as opposed to estimates
based on a single genus or clade) may be an underestimate.
Nonetheless, the authors concluded that Alphapapillomaviruses
diverged from their last common ancestor about 75 million years
ago. This suggests that the Alphapapillomavirus ancestor may have
existed prior to the divergence of the primate lineage. A similar
timeframe was obtained independently by using HPV18 LCR
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divergenece of the human papillomaviruses occurred before the
emergence of Homo sapiens. Under this hypothesis, it is to be
expected that each human Alphapapillomavirus species should be
mirrored by a non-human primate species. In fact, the observation
that papillomaviruses infecting non-human primates are found
intertwined with human speciﬁc types (as opposed to basal, see
above) provides strong support for this idea, and should not be
used to dismiss the role of co-evolution.Additional mechanisms driving papillomavirus evolution
Darwinian evolution
The assumption that papillomaviruses evolve only by genetic
drift implies that mutations became ﬁxed at the same rate across
the different ORFs. Since this is not the case (see above and Garcia-
Vallve et al. (2005) and Rector et al. (2007)), evolutionary forces
must differentially affect each individual ORF.
The effect of Darwinian (or diversifying) selection on the evolu-
tion of different papillomavirus ORFs has been studied in some
detail. The ratio of non-synonymous sites over synonymous sites
(dN/dS) estimates the relative importance of selection vs. genetic
drift (Kimura, 1977; Yang and Bielawski, 2000). A role for purifying
selection is suggested when the dN/dS ratio is smaller than
one. Usually these ratios are calculated as an average number
across an entire gene. However, given the availability of sufﬁcient
sequence date, the selective pressure at a single codon site can be
estimated.
To date, limited evidence for positive selection between viral
types has been described (Narechania et al., 2005b). An important
caveat is that the use of highly divergent sequences saturates the
evolutionary changes, thereby interfering with the analysis. How-
ever, even at the intra-type level (i.e., by comparing variant
genomes), only a few sites have been shown to be under
diversifying selection (Table 2). On the contrary, most of the
papillomavirus genes are under strong purifying selection, thereby
limiting changes to the encoded proteins (Carvajal-Rodriguez,
2008; Chen et al., 2005; DeFilippis et al., 2002). For example,
analysis of HPV16 found only seven codons to be under diversify-
ing selection (Carvajal-Rodriguez, 2008; Chen et al., 2005;
DeFilippis et al., 2002). It is difﬁcult to provide experimental
evidence for the processes involved in directional pressure, how-
ever available data allows us to hypothesize about potential
sources of pressure. For example, the arginine at position 17 in
the HPV16 E6 protein (Arg17) has been shown to be positively
selected (Table 2). This residue is involved in the interaction with
E6AP (Zanier et al., 2013). However, based on mutagenesis studies,
it is unlikely that Arg17 is being selected to stabilize this contact.
On the other hand, the cellular immune response may be applying
pressure on this Arg17 residue. The naturally occurring HPV16 E6
variant R10G was demonstrated to alter an HLA B*07 binding
epitope thereby inﬂuencing recognition by cytotoxic T lympho-
cytes (Ellis et al., 1995). Likewise, the Gln21 and Leu90 have been
shown to be located in HLA recognition epitopes (Ellis et al., 1995).
This would suggest that the heterogeneity of the host immune
response (and the outcome of infection) is actively selecting for
speciﬁc HPV16 variants.
In summary, it is hard to estimate the impact of Darwinian
selection throughout the virus' evolutionary history. However, it
appears that interactions with the host are driving the evolution of
E5, E6 and E7 proteins (Table 2). This is in agreement with the
proposed adaptive role of these proteins (see above). It is plausible
that due to their key roles throughout the viral lifecycle, E1, E2, L2and L1 do not tolerate mutations. The addition of more malleable
proteins capable of probing new cellular partners would provide a
distinct evolutionary advantage.
Bias in codon usage
Zhou and colleagues made one of the ﬁrst observations towards
the importance of codon usage by papillomavirus genes in 1999
(Zhou et al., 1999). Through changing a number of codons (towards
codons more frequently used in humans) the expression of the
BPV1 L1 and L2 improved signiﬁcantly. Furthermore, it was
shown that the use of rare tRNAs was indeed rate-limiting for
optimal protein translation. This led to the hypothesis that
papillomaviruses evolved to use rare codons, thereby limiting
the expression of viral proteins, minimizing detection by the
immune system.
Indeed, evidence exists that codons complementary to abun-
dant tRNAs provide many lower organisms with an evolutionary
advantage (Gouy and Gautier, 1982; Moriyama and Powell, 1997;
Powell and Moriyama, 1997; Sharp et al., 1986). However, in
mammals there is no clear link between protein abundance and
codon usage bias (Sharp et al., 1993). For example, human codon
usage bias is determined mainly by genome location and hence
mutation pressure acting differently on speciﬁc genes. While the
basis for the codon bias is not known, its importance during viral
replication and gene expression has been suggested (Zhou et al.,
1999).
The question remains what processes determine the observed
codon bias. The strong correlation between overall GC content and
papillomavirus codon bias argues that codon usage is primarily
determined by the local dinucleotide content. The viral dinucleo-
tide content is highly similar in genes with different functions and
genomic positions. Furthermore, the GC frequencies are similar
at synonymous and non-synonymous codon positions. This sug-
gests that genome-wide mutational processes, and not natural
selection (which would be expected to act primarily on the
non-synonymous codons) are responsible for the observed codon
bias in papillomavirus ORFs (Shackelton et al., 2006).
Papillomaviruses have small genomes that are jam packed with
open reading frames, many of which are overlapping. In addition
to overlapping ORFs, papillomaviruses contain a plethora of non-
coding functional elements embedded within ORFs. The presence
of these overlapping elements is likely to inﬂuence the viral codon
usage (Firth and Brown, 2006).
Therefore, no evidence exists to suggest that papillomaviruses
“actively” evolved to use sub-optimal codons. Nonetheless, the use
of sub-optimal codons may have shaped the evolutionary trajec-
tory of papillomaviruses. It has recently been suggested that codon
bias may be aimed at minimizing mutations at the protein level.
When hit by a nucleotide mutation, “robust codons” code for
amino acids with similar properties. For example, codons begin-
ning with TpA are rare, due to the risk of being mutated to a stop
codon (Shackelton et al., 2006). While human genes almost
exclusively use “robust codons”, almost all papillomavirus codons
are biased towards “risky codons” (Bravo and Muller, 2005).
This may, in part, provide an explanation for the exceptionally
low papillomavirus mutation rate (Duffy et al., 2008) as well as the
episodes of rapid radiation (e.g. at the root of the Betapapilloma-
virus) characteristic for the papillomavirus tree. The use of “risky
codons” implies that most mutations will prove detrimental for
the virus and will therefore not be ﬁxed in the viral genome.
The use of “risky codons” may minimize the effects of mutations
that may alter the ﬁne balance between the virus and the host
reached over millions of years of evolution. However, a rare non-
detrimental event would allow the newly minted protein-residue
to explore previous unavailable interactions.
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origin and potential (evolutionary) beneﬁt of this adaptation
remain elusive.Evolution of oncogenic risk within the Alphapapillomavirus
genus
The etiological link between persistent infection with speciﬁc
oncogenic papillomavirus types and (pre-) cancerous lesions of the
cervix has been well established (Schiffman et al., 2007). However,
since cellular transformation signals the end of the productive viral
infection, papillomaviruses clearly did not evolve to cause cancer.
Therefore, a (combination of) viral phenotype(s) essential for the viral
lifecycle, create a cellular environment at risk for malignant progres-
sion. In order to pinpoint these viral phenotypes, it is essential to gain
an understanding into the evolutionary changes that allowed speciﬁc
papillomavirus access to discreet host ecosystems.
As mentioned above, phylogenetic trees based on different parts
of the genome are incongruent. When the early genes are used, all
oncogenic Alphapapillomavirus types cluster into a monophyletic
group as shown in Fig. 4. However, the late genes split oncogenic
viruses into two separate clades (Narechania et al., 2005a). This
phylogenetic incongruence maps the genetic basis of pathogenicity
and oncogenicity to the early genes (Burk et al., 2009).
Phylogenetic analysis based on the early genes group all
oncogenic papillomavirus types into a single group. However,
not every papillomavirus within this group is actually oncogenic
(Bouvard et al., 2010). In addition, a clear spectrum of oncogenic
risk exists among the carcinogenic types in the high-risk clade
(Schiffman et al., 2009). This would suggest that a careful combi-
nation of evolutionary analysis coupled with epidemiological data
might be able to pinpoint the underlying genetic changes, espe-
cially the observation that certain variants of HPV16 show an
increased risk when compared to other variants reinforces this
possibility (Schiffman et al., 2010). Nevertheless, the underlying
nucleotide changes responsible for the association with cancer
have gone largely unsolved (Smith et al., 2011).
In an attempt to understand differences in oncogenic potential,
researchers have traditionally compared viral phenotypes between the
prototypical high- and low-risk types (HPV16/HPV18 vs. HPV6/HPV11)
(Klingelhutz and Roman, 2012). However, these viruses infect different
anatomical niches on the human body and are separated by approxi-
mately 30 million years of evolutionary changes. It is possible that the
observed differences in activity are due to differences in tissue tropism.
The interpretation of biochemical data through evolutionary glasses
should allow researchers to interpret the confounding effects of
evolutionary (niche) adaptation (Van Doorslaer and Burk, 2010).
Comparative genomics analyses have been performed to study the
impact of distinct viral phenotypes proposed to be important for
transformation (Fu et al., 2010; Hiller et al., 2006, 2008; Muench et al.,
2009; Van Doorslaer and Burk, 2010; 2012; Van Doorslaer et al., in
preparation). The ﬁndings in these studies have begun to shed light on
which viral phenotypes are correlated with oncogenic potential.
Comparative genomics may provide insights into the viral
phenotypes associated with oncogenicity; it does not explain
why (papilloma) viruses evolved these phenotypes. It is generally
assumed that the viral oncogenes target tumor suppressor path-
ways in order to usurp the cells’ replication machinery to achieve
successful viral replication. However, this view may be too
simplistic (reviewed in Moore and Chang (2010)). Studies
performed in the Gammaherpesviridae suggest a role of these
pathways in immune evasion as well as viral genome replication.
Interestingly, tumor suppressing and innate immunity pathways
may share many similarities (Moore and Chang, 2010). For exam-
ple, both cellular pathways converge on p53 (Takaoka et al., 2003)and p21 (Chin et al., 1996). The anti-antivirus hypothesis (Moore
and Chang, 1998, 2003) suggests that viruses target these path-
ways to interfere with the innate immune system, inadvertently
putting the cell at risk for oncogenic progression. While these
adaptations would allow papillomaviruses to persist longer in
their hosts, the overlap of these cellular functions implies that
these cells are also at increased risk for oncogenic transformation.Impact of vaccines on viral evolution
The highly successful human papillomavirus vaccine targets
infection by HPV16 and HPV18 (and HPV6/HPV11, depending on
the manufacturer). It is a concern that viruses not targeted by
the vaccine would invade the niche vacated through vaccination.
Some modeling approaches have suggested that the lack of cross-
reactivity (i.e., the vaccine only protects against virus types
included, not other related types) will drive the evolution of new
oncogenic virus types (Orlando et al., 2012). However, the data
summarized in this review clearly shows that papillomaviruses
evolve very slowly. In addition, epidemiological studies show that
a preexisting infection does not affect the probability of a second-
ary infection with a related virus (Kaasila et al., 2009; Plummer
et al., 2007). Providing further support that papillomaviruses are
highly niche speciﬁc and do not compete for ecological niches
within the epithelium (Stanley et al., 2006).
It is therefore highly unlikely that vaccination will result in the
emergence of novel oncogenic viruses in the near future. However,
there is little doubt that providing several million years, a virus
will eventually emerge to ﬁll this vacated niche. In addition, even
in the event of type replacement, the dramatically lower onco-
genic potential of the not-included viruses will likely mean that
the impact on public health will be manageable.
However, as mentioned above, recombination events may play
an important role in vaccine evasion. For example, a recombina-
tion event between HPV16 and HPV31 may result in a virus
capable of evading the vaccine-mediated immunity, while packing
the punch of a highly oncogenic virus. Especially in populations
(e.g. HIV+) at risk for infections with multiple viral types (Clifford
et al., 2006), the emergence of recombinants should be considered.Viral evolution in the genomics era
Even though the current papillomavirus sequence databases
provide a treasure-trove of sequence data, it is likely that these
viruses are only the tip of the iceberg. This is exempliﬁed by the
fact that most well studied host species contain a highly diverse
set of viruses. However, most amniote hosts have not been
sampled, and sampling has been minimal in most other cases.
In order to draw general conclusions about papillomavirus evolu-
tion we need to ﬁll in the gaps in the phylogenetic tree. The
conclusions presented in this review will remain premature until
more diverse genomes are discovered and available for analysis.
Just like the advent of PCR and Sanger sequencing provided
researchers with the tools to obtain viral sequence data, the rise
of pyrosequencing techniques (so called next-gen approaches) is
expected to vastly increase the rate of viral discovery. Excitingly, since
these approaches do not require prior sequence knowledge, it should
be possible to describe drastically novel viral types that would not be
detected using the standard consensus primer approach. However,
these advances in genome sequencing capabilities should not be used
simply to ﬁll our sequence databases with more and more sequence
information. If used to address the proper questions, these new
methods have the capabilities to illuminate many key issues in
(papillomaviral) evolution (Holmes, 2007). We cannot lose track of
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maximized when the genomics data is combined with epidemiologi-
cal and biochemical data. Therefore, as much as possible, we should
attempt to conﬁrm associations with the expected host range and
pathology.
Furthermore, an infection may give rise to a “cloud” of (minor)
viral populations around the prototype sequence, suggesting muta-
genesis of the viral genome inside the host cell. The APOBEC DNA
editing system may play a role in this phenomenon (Vartanian
et al., 2008). Yet, phylogenetic data provides convincing evidence
that papillomaviruses evolve slowly. This suggests that the “cloud”
of edited genomes does not get ﬁxed in the population. Next-gen
sequencing approaches may allow for a characterization of the viral
diversity in a single host (cell). This would provide new insights into
the evolutionary dynamics of this exciting family of viruses.Conclusion
Evolutionary analysis has come a long way since it emerged
from the ﬁeld of systematics. Papillomavirus researchers have a
wealth of sequence, epidemiological and biochemical data at their
disposal. For these and other reasons, papillomaviruses represent
an excellent model system to dissect the role of individual viral
nucleotides in all aspects of the viral lifecycle. Building on these
arguments, evolutionary analyses will allow researchers to iden-
tify those evolutionary changes conferring carcinogenic potential
to oncogenic viruses. In addition, evolutionary analysis can, and
should, guide the design of mutational studies aimed at under-
standing the role of a speciﬁc protein during the lifecycle.
In short, a thorough understanding of the papillomaviral
evolutionary history can and will beneﬁt every aspect of papillo-
mavirus research.Acknowledgments
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